Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
نویسندگان
چکیده
We read with interest the article from Shanin et al. about the Fungal Infection Risk Evaluation (FIRE) study [1] aiming to ‘describe the incidence of IFD in UK critical care units and to develop and validate a clinical risk prediction tool to identify non-neutropenic, critically ill adult patients at risk of IFD’. The investigators should be congratulated for the way they collected a huge amount of data from 96 adult intensive care units (ICUs), managed the FIRE database, and developed and validated the risk model. However, they stated that the prediction model would help to identify patients who may benefit from antifungal prophylaxis and that a number of randomized controlled trials (RCTs) demonstrated a beneficial effect of antifungal prophylaxis and/or empiric treatment in terms of incidence of invasive fungal disease (IFD) and mortality. This statement is not supported by available evidence from RCTs. A recent Cochrane Systematic Review including 22 RCTs evaluating prophylaxis, pre-emptive, and empiric antifungal treatment with any antifungal drugs in 2761 non-neutropenic critically ill patients showed no significant effect on mortality (risk ratio (RR) 0.93, 95 % confidence interval (CI) 0.79 to 1.09) and a significant reduction in the risk of invasive fungal infection (IFI) (RR 0.57, 95 % CI 0.39 to 0.83) [2, 3]. In the subgroup analysis for type of intervention, antifungal prophylaxis was not associated with a significant mortality reduction but with a significant reduction of IFI [4]. This systematic review was the update of the one cited in the manuscript and published in 2006 including 12 RCT and 1606 patients. Resistance to antifungals has become an increasingly burning clinical challenge. It concerns not only azoles but also the relatively new echinocandins [5]. Notably, the increasing use of antifungal drugs is linked to the development of resistance, whereas infections by resistant Candida spp. are linked to worse outcome [5]. How should predictive tools be used to identify patients at risk of IFI? What should we do after identifying a patient at risk of IFI while waiting for microbiology results? Maybe the answer should not be just giving antifungal prophylaxis as we did in the past. A more complex approach including the use of surrogate markers (e.g., beta-D-glucan), early use of other diagnostic test (e.g., multiplex polymerase chain reaction test, MALDITOF), source control, daily evaluation of risk factors, and, finally, in some cases the wise use of antifungal drugs according to local epidemiology may be answer. To simplify, antifungal stewardship is what we should implement to balance risk and benefit.
منابع مشابه
Deep seated Candidiasis
Candida pneumonia is classified as primary when there is no other hematogenous manifestation of candidiasis. The infection is rare and usually is the result of aspiration. Secondary candida pneumonia, the most frequent presentation, is associated with hematogenous candidiasis. Among cancer patients, only 9% of pulmonary candidiasis cases were considered primary. Cardiovascular infections caused...
متن کاملعفونت های قارچی بیمارستانی: اپیدمیولوژی، تشخیص، درمان و پیشگیری
Nosocomial fungal infections are amongst the main causes of mortality in patients admitted to healthcare settings, especially in immunocompromised populations. The predominant pathogens include Candida spp., Aspergillus spp., Mucorales spp., and Fusarium spp. Nosocomial fungal infections are increasing due to the underlying factors in decades ahead. One of the predisposing factors i...
متن کاملکلونیزاسیون کاندیدایی در نوزادان بخش مراقبتهای ویژه و شناسایی گونهها با روشهای قارچشناسی و مولکولی
Background: Over the last two decades invasive candidiasis has become an increasing problem in neonatal intensive care units (NICUs). Colonization of skin and mucous membranes with Candida spp. is important factor in the pathogenesis of neonatal infection and several colonized sites are major risk factors evoking higher frequencies of progression to invasive candidiasis. The aim of this study w...
متن کاملشناسایی گونههای کاندیدا با روشهای قارچشناسی و مولکولی در زنان باردار مبتلا به کاندیدیازیس واژینال
Background: Vaginal candidiasis is common in during pregnancy. It may lead to complications like abortions, premature birth, low birth weight, chorioamnionitis and fungal systemic neonatal infection. The aim of present study was identification of Candida species by mycological and molecular methods in pregnant women with vaginal candidiasis. Methods: This cross-sectional study was performed on...
متن کاملEpidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India
Background and Purpose: The incidence of fungal infection as well as candidemia has increased significantly, contributing to morbidity and mortality in the developed countries. The alarming increase in infections with multidrug resistant bacteria is due to overuse of a broad spectrum antimicrobials, which leads to over growth of Candida spp.; thus, enhancing its opportunity to cause the disease...
متن کامل